Hyperlipidemias
Showing 26 - 50 of 676
HIV/AIDS, Hypertension, Hyperlipidemias Trial in Durham, Cleveland (Multi-component intervention, General prevention education)
Completed
- HIV/AIDS
- +2 more
- Multi-component intervention
- General prevention education
-
Durham, North Carolina
- +2 more
Jan 23, 2023
Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder Trial in Moscow (Pitavastatin, PCSK9 inhibitor)
Recruiting
- Dyslipidemias
- +5 more
- Pitavastatin
- PCSK9 inhibitor
-
Moscow, Russian FederationNational Medical Research Centre for Therapy and Preventive Medi
Sep 8, 2022
Cardiometabolic Disease, Hyperlipidemia Trial in Beijing (Telehealth integrated care, Conventional health care)
Recruiting
- Cardiometabolic Disease
- Hyperlipidemia
- Telehealth integrated care
- Conventional health care
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 1, 2023
Cardiovascular Diseases, Myocardial Infarction, Atrial Fibrillation Trial in New York (Care coordination delivered based on
Not yet recruiting
- Cardiovascular Diseases
- +9 more
- Care coordination delivered based on perceived need
- Care coordination delivered based on usual care (e.g. discharge from hospital)
-
New York, New YorkNew York Presbyterian Hospital - Weill Cornell Medicine
Apr 7, 2023
Obesity, Obesity, Morbid, Obesity, Primary Trial in Boston (Blood Collection, Urine Collection, Tissue Sample Collection)
Not yet recruiting
- Obesity
- +16 more
- Blood Collection
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
May 23, 2023
Hyperlipidemia, Hyperglycemia, Type 2 Diabetes Trial in Taipei (Adlay with white rice, white rice)
Recruiting
- Hyperlipidemia
- +2 more
- Adlay with white rice
- white rice
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 17, 2023
Hyperlipidemias Trial in Dhaka (Zinc sulfate, Placebo)
Recruiting
- Hyperlipidemias
- Zinc sulfate
- Placebo
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
May 24, 2022
Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))
Recruiting
- Hyperlipidemias
- Evolocumab
- Statins (Cardiovascular Agents)
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 18, 2022
Hyperlipidemias Trial in Portland (Fruit and vegetable deliveries)
Completed
- Hyperlipidemias
- Fruit and vegetable deliveries
-
Portland, OregonOregon Health & Science University
Apr 18, 2022
Obesity, Hyperlipidemias Trial in Singapore (Simvastatin)
Recruiting
- Obesity
- Hyperlipidemias
-
Singapore, SingaporeNational University Hospital
Apr 7, 2022
Hyperlipidemia Trial in Beijing (JS401, Placebo)
Recruiting
- Hyperlipidemia
- JS401
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 15, 2023
Lipoprotein Metabolism in Normal Volunteers and High Levels of
Completed
- Hypolipoproteinemia
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Inflammation, Hypertriglyceridemia, Metabolic Disease Trial in Bozeman (Lentil, Control)
Recruiting
- Inflammation
- +5 more
- Lentil
- Control
-
Bozeman, MontanaNutrition Research Laboratory
Apr 6, 2022
Hypertriglyceridemia Trial in Hellerup (DHA-NAT, Placebo)
Recruiting
- Hypertriglyceridemia
- DHA-NAT
- Placebo
-
Hellerup, DenmarkCenter for Clinical Metabolic Research, Herlev-Gentofte Hospital
Jul 11, 2023
Diabetes, Lipodystrophy, Hyperlipidemia Trial run by the NIDDK (Metreleptin)
Active, not recruiting
- Diabetes
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Hyperlipidemias, Hypercholesterolemia Trial in Cheras (Placebo, 250 mg OPP)
Completed
- Hyperlipidemias
- Hypercholesterolemia
- Placebo
- 250 mg OPP
-
Cheras, WP Kuala Lumpur, MalaysiaNational University of Malaysia
Apr 5, 2022
Hypertension and Hyperlipidemia Trial in Philadelphia (HTN and Medication Adherence)
Recruiting
- Hypertension and Hyperlipidemia
- HTN and Medication Adherence
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 27, 2022
Program With Lipid Screening asMeans to Identify Familial
Enrolling by invitation
- Familial Hyperlipidemia
-
Loveland, ColoradoMedical Center of the Rockies
Mar 2, 2023
Lipodystrophy, Diabetes, Hyperlipidemia Trial run by the NIDDK (Metreleptin)
Recruiting
- Lipodystrophy
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity
Not yet recruiting
- Acute Coronary Syndrome
- +3 more
- Placebo plus high-intensity statin
- PCSK 9 Inhibitor plus high-intensity statin
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Aug 1, 2022
NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2, Hyperlipidemias Trial in Frankfurt, Mainz (Nutritional Intervention)
Active, not recruiting
- NASH - Nonalcoholic Steatohepatitis
- +2 more
- Nutritional Intervention
-
Frankfurt, Germany
- +1 more
Mar 28, 2022
Improving Systolic BP and LDL-C Compared to Conventional
Not yet recruiting
- Hyperlipidemias
- Hypertension
- Rosuvastatin, Olmesartan Medoxomil
- (no location specified)
Jun 6, 2022